These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 5756803)
61. [Treatment of venous disorders in women]. Delacroix P Sem Hop; 1980 Oct 18-25; 56(39-40):1599-601. PubMed ID: 6255576 [No Abstract] [Full Text] [Related]
62. [Results of clinical testing of a circulatory geriatric agent with vitamins]. Bense K; Schwarz A Landarzt; 1967 Dec; 43(34):1690-1. PubMed ID: 5610818 [No Abstract] [Full Text] [Related]
63. [Vasodilator agents]. Bollinger A Schweiz Med Wochenschr; 1967 Sep; 97(37):1225-7. PubMed ID: 4874428 [No Abstract] [Full Text] [Related]
64. [Our experience in the treatment of peripheral vascular diseases with raubasine]. Vercellio G; Costantini S; Giulini S Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726 [No Abstract] [Full Text] [Related]
65. [Experience with the vasodilator agent spasmocyclone]. Priessnitz O Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718 [No Abstract] [Full Text] [Related]
69. [Use of ambulatory medical care in cardiovascular diseases--a prescription analysis]. Froböse HH; Ankermann H Z Arztl Fortbild (Jena); 1984; 78(11):451-4. PubMed ID: 6475121 [No Abstract] [Full Text] [Related]
71. [Combined treatment of peripheral perfusion disorders with vasodilators and physiotherapy]. Baitsch G; Baitsch R Munch Med Wochenschr; 1968 Oct; 110(42):2456-63. PubMed ID: 5755166 [No Abstract] [Full Text] [Related]
72. [Ophthalmoscopic and functional changes in vascular lesions of the optic nerve]. Miroshnikova LM; Drozdovskaia VS; Smidovich LG Oftalmol Zh; 1983; 38(6):342-4. PubMed ID: 6646591 [No Abstract] [Full Text] [Related]
73. [Use of a compound of Euclidan and synthetic local anesthetics, by endarterial injection, in the treatment of 45 cases of vascular disease. Clinical results]. Reboul H; Vergoz L Clinique (Paris); 1965 Jun; 60(608):449-60. PubMed ID: 5845021 [No Abstract] [Full Text] [Related]
74. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases]. Simões Neto E Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651 [No Abstract] [Full Text] [Related]
75. [Vascularization in the prelaminar region of the optic papilla]. Theodossiadis GP Klin Monbl Augenheilkd; 1971 May; 158(5):646-52. PubMed ID: 5578946 [No Abstract] [Full Text] [Related]
76. [Results of a 5-year follow-up study and prognosis in patients with cardiac insufficiency]. Krol VA; Nasonova TI; Buianova NL; Novikov ID; Iurenev AP Ter Arkh; 1989; 61(1):67-9. PubMed ID: 2718126 [No Abstract] [Full Text] [Related]
77. [Vasodilator drugs in the treatment of peripheral arterial diseases]. Lorentsen E Tidsskr Nor Laegeforen; 1967 Jun; 87(11):1054-7. PubMed ID: 4860122 [No Abstract] [Full Text] [Related]
78. [Action of 1035 MD on senile macular degeneration; its normotensive effect on the central retinal artery]. Jézégabel C; Rossazza C Bull Soc Ophtalmol Fr; 1970; 70(7):790-7. PubMed ID: 5526305 [No Abstract] [Full Text] [Related]
79. [Action of MD 1035 in peripheral vascular manifestations]. Barraine R; Efthymiou TP; Marcantoni JP Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156 [No Abstract] [Full Text] [Related]
80. [Geriatrics and the eye]. Kurz M Klin Monbl Augenheilkd; 1969 May; 154(5):722-5. PubMed ID: 4242819 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]